To establish an incorrect statement by the insured, it is necessary to prove the intention to deceive the insurer.

The insurance field is often at the heart of numerous controversies related to the truthfulness of the declarants’ statements. Policyholders are required to provide accurate and complete information when subscribing to a contract, as their declaration influences the insurer’s risk assessment. However, when discrepancies arise, especially during claims, the critical issue becomes that of proving an intention to deceive the insurer. This issue raises multiple legal and practical challenges for companies such as AXA, Allianz, MAAF, or Groupama, as well as for the policyholders themselves. It should be noted that the contractual balance relies on mutual trust, often put to the test by contentious situations highlighted in the news.

It should be emphasized that omission or inaccurate declaration does not automatically undermine the validity of an insurance contract. Indeed, the fraudulent intent of the policyholder must be demonstrated: it is not merely a case of error or misunderstanding, but a deliberate attempt to conceal the truth. This principle, already established in insurance law, has been repeatedly confirmed by case law and regulated by recent reforms aimed at better protecting policyholders while ensuring the solvency of companies.

This article explores the mechanisms of this evidence requirement, analyzing the criteria and trigger elements allowing an insurer such as Generali or Swiss Life to initiate a definitive action to cancel a contract for intentional false declaration. Concrete examples from daily practice and notable cases handled in 2025 highlight the subtleties of this complex but essential procedure to maintain trust in the insurance system. Finally, the impact of these mechanisms on the entire insurance chain, including contract distribution through actors like CNP Assurances, Mutuelle Générale, and LCL Assurances, will also be examined.

Legal framework of inaccurate declaration according to insurance law in 2025

Insurance law is based on solid foundations establishing the obligations of contracting parties. Article L113-8 of the Insurance Code, often cited in disputes over inaccurate declarations, states that the insurer has a fixed period to cancel the contract or reduce benefits when it notices an omission or inaccuracy in the risk declaration by the policyholder. However, the main issue lies in proving bad faith, that is, the explicit intention to deceive the insurer at the time of subscription.

It should be noted that the reform of contract law, whose principles are detailed at this specialized resource, emphasizes the importance of loyalty and good faith as the foundations of the insurance contract. Thus, for a false declaration to be recognized as intentional, the insurer must demonstrate three essential elements:

• The inexact declaration or omission
• The deliberate intent to deceive, characterized by obvious bad faith
• The significant influence of the statement on the insurer’s decision to accept the risk or to calculate the premium

The absence of any of these criteria can lead to a favorable outcome for the policyholder, who retains coverage under their contract and benefits from compensation in case of a claim. For insurers like AGF and MAAF, this requirement acts as a barrier to automatic recourse and requires rigorous proof, notably obtained through in-depth investigations.

Key Element 🔍	Description 📄	Impact on the Contract ⚖️
Inaccurate declaration	Misleading information or omission of important facts	Justifies a thorough review of the case file
Intent to deceive	Manifest desire to conceal or falsify facts	May lead to nullity of the contract
Influence on risk assessment	Data impacting the premium or coverage	Confirms the relevance of contestation

Proof procedure: how insurers establish the intent to deceive

Determining with certainty that the policyholder intended to deceive the insurer is a particularly delicate exercise. Companies implement specific procedures, combining legal expertise and field investigations. For example, Swiss Life deploys specialized teams in detecting false declarations, combining analyses of medical files, historical claims investigations, and cross-referencing of information.

This proof phase includes several main steps:

• Detailed analysis of initial declarations and provided documents 🌐
• Collection of testimonies and additional information from third parties 📞
• Consultation with medical or technical experts depending on the nature of the contract 🩺🔧
• Comparison with the client’s historical data and national databases 📊🗃️
• Contradictory interview with the policyholder to verify coherence 🤝

This protocol aims to convince a court or arbitration authority that fraudulent intent was present from the signing of the contract or at the time of the claim declaration. The rigor of investigations is crucial when establishing contract nullity or reducing indemnities, especially concerning major actors like CNP Assurances or Mutuelle Générale.

Key Step 🔎	Objective 🎯	Methods Used 🛠️
Document analysis	Identify inconsistencies and omissions	Medical passport, expert notes, declarations
Field investigations	Verify the actual context of declarations	Testimonies, visits, external cross-referencing
Contradictory questioning	Assess coherence of the policyholder’s version	Video or face-to-face interviews

These investigation processes impact the insurer-policyholder relationship. A major challenge is to preserve trust while sanctioning proven misconduct, as illustrated by recent cases analyzed in files involving health insurance frauds widely covered in the press (see this specific case).

Distinction between error and intentional false declaration in insurance

In the complexity of insurance files, it is crucial for sector professionals to distinguish a simple error from an intentional false declaration. This differentiation determines the legal and financial outcome of the dispute. The insurer cannot invoke the nullity of the contract without a concrete element characterizing bad faith.

Bad faith is mainly characterized by:

• Voluntary concealment of important information 🤫
• Deliberate falsification of provided data ✍️
• Refusal to answer questions honestly ❌

Conversely, an error can result from:

• Unintentional misunderstandings or misinterpretations of questions 🤔
• Involuntary forgetfulness or negligence 🕒
• Incorrectly interpreted or communicated data 🗒️

Recent case law from 2025 reinforces the presumption of good faith against policyholders, placing greater pressure on insurers like Generali or AGF to produce tangible and detailed evidence before any sanctions. This contributes to fairer relationships within contractual dealings.
A comparative table highlighting these differences is provided:

Characteristic 📌	Error 🟢	Intentional false declaration 🔴
Nature	Unintentional, accidental	Deliberate, intentional
Legal consequence	No penal effect if not repeated	Nullity of the contract, denial of indemnity
Burden of proof	On the insurer to prove bad faith	Mandatory and strict to apply corrective measures

The fine distinction between these two notions is a fundamental pillar to ensure the balance and sustainability of contractual relationships in the sector, especially in a context where fraudulent practices are closely scrutinized (see also fraud analysis in Charente-Maritime).

Impact of intentional false declarations on the insurance market

Intentional false declarations disrupt not only the contractual relations between the policyholder and the insurer but also have significant economic and social consequences on the insurance market.

These fraudulent behaviors lead to:

• A significant increase in premiums for all policyholders 💸
• Strengthening controls and investigative procedures that prolong processing times ⏳
• Deterioration of trust between policyholders and insurance companies ⚖️
• A rise in legal disputes involving lengthy litigation and mediations ⚖️⚔️

Groups such as AXA, LCL Assurances, or CNP Assurances are heavily investing in artificial intelligence systems and analytical tools to detect inconsistencies in declarations and anticipate potential fraud. This modernization aims to enhance efficiency while limiting the risk of an unmanageable volume of unjustified files.

Consequence 🚨	Detailed Explanation 📋	Concerned Actors 🏢
Premium increase	The cost of fraud is passed on to all policyholders	Operators and individual clients
Tightening procedures	More rigor in data collection upfront	Companies such as Generali, MAAF
Increase in disputes	Long time required to resolve conflicts related to false declarations	All stakeholders

Insurance facing fraud: prevention strategies and tools

In response to the rise in inaccurate declarations, sometimes made with deceptive intent, insurance companies are strengthening efforts to develop effective prevention mechanisms. Among the leaders, Swiss Life, Groupama, and MAAF collaborate with data science experts to design early warning systems based on behavioral analysis and anomaly detection.

The tools deployed include:

• Centralized databases to cross-reference declarations with public and private data 🔗
• The use of artificial intelligence to identify risky or incoherent profiles 🤖
• Regular audits of policyholder files to verify consistency with their history 📂
• Awareness campaigns for clients to emphasize the importance of good faith 💬

These approaches are complemented by strict enforcement of legal sanctions, aiming to deter fraudulent behaviors while protecting honest policyholders. In particular, practices at AGF and Mutuelle Générale support a vital balance for the financial health of companies and the credibility of the entire sector.

Prevention tool 🛡️	Concrete explanation 💡	Expected benefit 🎯
Cross-referenced databases	Gathering of national and private information	Increased reliability of declarations
Artificial intelligence	Predictive analysis of anomalies	Rapid detection of frauds
Regular audits	Random checks of client files	Maintaining contractual prudence
Client awareness campaigns	Information campaigns on good faith	Reduction of involuntary errors

Illuminating case law examples on evidence of deceptive intent

Case law plays a central role in precisely defining the boundaries of intentional false declaration in insurance matters. Several landmark decisions over recent years demonstrate the criteria adopted by courts when examining these cases.

Among these rulings, two cases clearly illustrate the principle:

1. An insured deliberately underreported a significant medical history, ignoring repeated requests from their insurer for clarification, leading to the nullification of the contract.
2. An enterprise hiding risk factors in its initial declaration, engaging liability for false declaration and reducing coverage for damages.

These decisions reiterate that the policyholder’s good faith is always presumed and that the burden of proof lies with the insurer. They also rest on the rule that misrepresentation is sanctioned only if it influences risk evaluation accepted by the insurer.

Case 📚	Type of false declaration 🔍	Judicial decision ⚖️
Incorrect medical declaration	Omission of a serious antecedent	Contract cancellation
Omission of industrial risks	Deliberate concealment	Coverage reduction

This case law framework serves as a warning to insurers and an encouragement for transparency among policyholders, illustrating a necessary balance within contracts. To deepen understanding, recent cases of health insurance fraud analyzed on this specialized case file have been reported.

Role of experts in detecting and confirming false declarations

Experts play a pivotal role in the assessment process of the policyholder’s declaration. Whether medical, technical, or financial, their analyses provide factual elements that can corroborate or disprove the intent to deceive the insurer.

Their involvement is broken down into several phases:

• Precise evaluation of documents and testimonies related to the insured risk 📑
• Detailed report indicating inconsistencies or suspicious omissions 🔎
• Contradictory expertise involving both parties to ensure fairness ⚖️
• Recommendations for next steps based on findings 🗂️

Medical experts are particularly active in health and welfare insurance and are often contacted by groups like Groupama or LCL Assurances for in-depth review of medical histories or accident circumstances.

Category of expert 🧑‍⚕️	Areas of intervention 📚	Key contribution 🔑
Medical	History, diagnostics, disability	Objective assessment of health status
Technical	Material conditions, claims, risks	Analysis of causes and consequences
Financial	Valuation of losses and damages	Accurate estimation of amounts involved

The neutrality and independence of experts are essential to ensure the credibility and acceptability of their conclusions. This expertise is a fundamental pillar in demonstrating good faith or deception by the policyholder.

Ethical and social issues surrounding challenge procedures for declarations

Beyond technical and legal aspects, handling false declarations raises major ethical questions. Insurers must navigate between combating fraud and safeguarding policyholders’ rights, in a society where access to insurance is a significant social issue.

It is necessary to respect several principles, including:

• The right to privacy and data protection 🔐
• Fair procedure ensuring the right to effective recourse ⚖️
• Prevention of discrimination related to complex declarations or sensitive data ⚖️🚸
• Transparency in communicating motives and evidence provided by the insurer 🗣️

Highlighting these ethical issues also encourages increased dialogue among sector stakeholders, regulatory authorities, and users. This human-centered approach is already integrated into strategies of companies such as CNP Assurances or Mutuelle Générale, aiming to combine rigor with respect for fundamental rights.

Ethical Issue 🔍	Detailed description 📖	Practical consequence ✍️
Data confidentiality	Strict protection of medical and personal information	Limitation of access and compliance with GDPR standards
Procedural fairness	Ensuring impartial and transparent treatment	Right to appeal and clear explanations
Fight against discrimination	Avoiding biased decisions based on prejudices	Operator training and internal audits

These dimensions emphasize the importance of balanced management, which does not automatically lead to suspicion but promotes decisive action while respecting fundamental insurance law principles. This vigilance is increasingly important in a context marked by rising fraud and tensions between policyholders and insurers.

Future perspectives and evolutions in proof of intentional false declaration

By 2030, technological and legal advances are expected to refine the mechanisms for distinguishing false declarations from errors. Predictive analysis based on artificial intelligence, combined with reinforced regulation, should facilitate proving good faith or deception.

Among anticipated developments are:

• The development of automated tools for proactive incoherence detection 🤖
• European harmonization of rules and practices regarding evidence 👩‍⚖️
• Enhancement of defense rights with digitalized dispute platforms ⚖️📱
• Greater transparency in pricing to ensure better understanding of risk criteria 💡

These innovations could fundamentally alter the relationship between policyholders and insurers by making processes more streamlined and reducing unnecessary conflicts. However, they must be implemented with strict respect for individual rights and ethical standards to avoid abuses.

Future outlook 🔭	Description 🌐	Anticipated impact 🚀
AI analysis tools	Ability to automatically cross-reference large amounts of data	Reduced errors and fraud risk
Regulatory harmonization	Common standards across Europe on proof and sanctions	Better legal predictability
Digitalized dispute platforms	Simplified procedures for contestation	Easier access to recourse
Pricing transparency	Clear explanations of evaluation criteria	Increased policyholder confidence

These trends align with initiatives already undertaken by companies like Groupama and AXA, which are establishing partnerships with startups specializing in data technologies and law. The evolution is thus part of an ongoing improvement dynamic where the key criterion will remain tangible proof of intent to deceive.

Practical FAQ on proving an inaccurate declaration with intent to deceive

• ❓What characterizes an intentional false declaration in insurance?
  It involves deliberately misleading or concealed information that influenced the insurer’s decision.
• ❓Which organization can assist policyholders in case of dispute with their insurer?
  Consumer associations and insurance mediators are authorized to support policyholders.
• ❓What are the risks for a policyholder in case of proven intentional false declaration?
  The contract may be canceled, guarantees denied, and criminal proceedings may be initiated.
• ❓How to prove an error rather than an intention to deceive?
  By demonstrating a lack of deliberate intent, often through supporting documents or declarations of good faith.
• ❓Can insurers use technologies to detect fraud?
  Yes, increasingly, players like MAAF and Swiss Life invest in AI analysis tools to anticipate risks.